SL Therapeutics, Inc. (XKON: 258540)
1,268.00
+43.00 (3.51%)
Sep 10, 2024, 9:00 AM KST
SL Therapeutics Company Description
SL Therapeutics, Inc. engages in cell therapy and medical device businesses.
The company develops cell therapeutic solutions based on its cell reprogramming technology to treat various diseases with a focus on spinal cord injury, and age and genetically related diseases; and hair follicle cells, skin cells, and cells of the central nervous system.
It also manufactures automated magnetic resonance imaging systems; and Supra Elite and Dexino bone mineral density measurement devices.
The company was formerly known as StemLab Inc. SL Therapeutics, Inc. was founded in 2011 and is headquartered in Seoul, South Korea.
SL Therapeutics, Inc.
Country | South Korea |
Founded | 2011 |
Industry | Commercial Physical and Biological Research |
CEO | Jong Sung Choi |
Contact Details
Address: 711, Techno Complex of Korea University Seoul, 02841 South Korea | |
Phone | 82 2 2070 1177 |
Website | stemlab.co.kr |
Stock Details
Ticker Symbol | 258540 |
Exchange | Korea New Exchange |
Reporting Currency | KRW |
SIC Code | 8731 |
Key Executives
Name | Position |
---|---|
Jong Sung Choi | Chief Executive Officer |